Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Comment by JMark80on Nov 23, 2019 12:19am

32 Views

Post# 30384806

RE:RE:RE:🤡 JACKBOZO 🤡BEEN PLAYED!! LOLOLOL

RickyAlex444 wrote: JackBOZO threw away $15,000 plus much more on this scam !! LOLOLOL

Impossible to imagine you being able to live on your own, but I seriously doubt anyone would put up with/support you. Do you live with your parents? Rooming house? Group home? Which is it Penny? LOLOL LOLOLOL BAHAHAHAHA BAHAHAHAH LOLOLOL BAHAHAHA.

Bullboard Posts

What will the U.S. election results mean for Canada?